This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Johnson & Johnson (JNJ)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 70.07B 74.33B 71.31B 67.22B
Cost of Sales 21.54B 18.85B 18.24B 17.99B
Gross Operating Profit 48.54B 55.48B 53.07B 49.23B
Selling, General, and Administrative Expenses 21.20B 21.95B 21.83B 20.87B
Research & Development 9.05B 8.67B 8.18B 7.67B
Operating Income before D & A (EBITDA) 18.29B 24.85B 23.06B 20.70B
Depreciation & Amortization n.a. 3.90B 4.10B 3.67B
Interest Income n.a. 67.00M 74.00M 64.00M
Other Income - Net 1.33B 70.00M -2.50B -1.63B
Special Income / Charges n.a. 0.00 -1.16B -2.33B
Total Income Before Interest Expenses (EBIT) 19.62B 21.10B 15.95B 14.31B
Interest Expense 424.00M 533.00M 482.00M 532.00M
Pre-Tax Income 19.20B 20.56B 15.47B 13.78B
Income Taxes 3.79B 4.24B 1.64B 3.26B
Minority Interest 0.00 0.00 0.00 -339.00M
Net Income From Continuing Operations 15.41B 16.32B 13.83B 10.51B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 15.41B 16.32B 13.83B 10.51B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 15.41B 16.32B 13.83B 10.85B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 16.32B 14.41B 11.68B
Preferred Dividends
Net Income Available To Common 0.00 16.32B 13.83B 10.51B
Basic EPS from Continuing Ops. 5.57 5.80 4.92 3.94
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 5.57 5.80 4.92 3.94
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 5.57 5.80 4.92 3.94
Basic Normalized Net Income/Share n.a. 5.80 5.13 4.38
EPS fr Continuing Ops. 5.48 5.70 4.81 3.86
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 5.48 5.70 4.81 3.86
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 5.48 5.70 4.81 3.86
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 5.70 5.01 4.29
Dividends Paid per Share 2.95 2.76 2.59 2.40
JNJ News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

JNJ Johnson & Johnson

Chart of JNJ

Analysts Ratings for JNJ

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 7 6
Moderate Buy 1 1 1 2
Hold 6 6 6 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET JNJ ANALYST REPORT

JNJ Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs